TL;DR: Rosebud Biosciences is a Y Combinator Winter 2022 startup Growing micro-organs to find new drugs, currently active with a team of 3.
Growing micro-organs to find new drugs
Last verified:
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.
Built by LemStudio
Yes. Rosebud Biosciences was funded by Y Combinator in the Winter 2022 batch. Growing micro-organs to find new drugs
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids a…
Rosebud Biosciences was part of Y Combinator's Winter 2022 batch.
Rosebud Biosciences has a team of 3 people according to Y Combinator's directory.
Rosebud Biosciences is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…